A Co-Inhibitory Alliance in Myeloid Leukemia: TIM-3/Galectin-9 Complex as a New Target for Checkpoint Blockade Therapy

EBioMedicine. 2017 Sep;23:6-7. doi: 10.1016/j.ebiom.2017.08.002. Epub 2017 Aug 4.
No abstract available

Publication types

  • Comment

MeSH terms

  • Galectins*
  • Hepatitis A Virus Cellular Receptor 2*
  • Humans
  • Leukemia, Myeloid

Substances

  • Galectins
  • Hepatitis A Virus Cellular Receptor 2